Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205990
Company: NOVITIUM PHARMA

Products on ANDA 205990

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IMATINIB MESYLATE	IMATINIB MESYLATE	EQ 100MG BASE	TABLET;ORAL	Discontinued	None	No	No
IMATINIB MESYLATE	IMATINIB MESYLATE	EQ 400MG BASE	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205990

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/08/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.